India's First MRNA COVID Vaccine Gets DCGI Nod For Phase 2/3 Trials
[email protected]21 Sep, 2021News
The mRNA-based vaccine has been developed in partnership with Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC). ?Gennova Biopharmaceuticals Ltd., which is a Pune-based biotechnology company, had submitted the interim clinical data of the Phase I study to the Central Drugs Standard Control Organisation (CDSCO) and the Centre's National Regulatory Authority (NRA).
Related Bookmarks
- ANA Cargo joins Pharma.Aero for end-to-end air transportation of pharma cargo
- GEODIS to start service between Europe and Asia
- How to get high quality rural internet
- 3 simultaneous raids on gross allegations of non-revenue assets
- Cricket superstar Virat Kohli crushed in 200th IPL match for Bangalore
- Best Roulette Wining trick | Game to earn real money
- Egyptian actress Rosaline Elbay to star in Netflix drama
- Gatwick's Northern Runway cargo volumes forecast to reach 350,000 tonnes by 2047
- Lawyer says US journalist in Myanmar jail seems disheartened
- World No. 1 Nelly Korda joins Saudi Aramco Team Series golf championship in New York
Recent Profiles
Dubaijobfinderofficial
Bv789
789f
Kkkkkpg
Ae888vinsa
Xoilactvzztz Co Scam
Enduring Design Architecture
Precision Data Strategies Llc
Vwin
Hb88